Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infection in the Elderly”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05633992
What this trial is testing

Safety and Immunogenicity of V116 in Vaccine-naïve Japanese Older Adults (V116-009, STRIDE-9)

Who this might be right for
Pneumococcal Disease
Merck Sharp & Dohme LLC 450
Testing effectiveness (Phase 2)UnknownNCT04954131
What this trial is testing

Immunogenicity and Safety Study of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adultsin China

Who this might be right for
COVID-19
Zhejiang Clover Biopharmaceuticals, Inc. 766
Testing effectiveness (Phase 2)Study completedNCT00336453
What this trial is testing

Immunogenicity and Safety of FluBlok Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Pediatrics

Who this might be right for
Influenza
Protein Sciences Corporation 156
Testing effectiveness (Phase 2)Study completedNCT00726700
What this trial is testing

Pegfilgrastim and Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Aggressive B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
Universität des Saarlandes 109
Large-scale testing (Phase 3)Study completedNCT05879107
What this trial is testing

Study to Assess the Immune Response, the Safety and the Reactogenicity of Respiratory Syncytial Virus (RSV) Prefusion Protein 3 Older Adult (OA) (RSVPreF3 OA) Investigational Vaccine When co Administered With PCV20 in Older Adults

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,113
Large-scale testing (Phase 3)Study completedNCT01229371
What this trial is testing

Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Suppliers

Who this might be right for
Influenza
Crucell Holland BV 440
Early research (Phase 1)Study completedNCT05197075
What this trial is testing

Assess the Acceptability of the Darunavir/Cobicistat (DRV/COBI) Fixed-dose Combination (FDC) Tablet in Human Immunodeficiency Virus (HIV)-1 Infected Children

Who this might be right for
Human Immunodeficiency Virus (HIV)
Janssen Research & Development, LLC 15
Early research (Phase 1)Study completedNCT06604767
What this trial is testing

Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus InfectionMetapneumovirus InfectionParainfluenzae Virus Infection
Sanofi Pasteur, a Sanofi Company 390
Large-scale testing (Phase 3)Study completedNCT00552279
What this trial is testing

Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 805
Large-scale testing (Phase 3)Ended earlyNCT03376321
What this trial is testing

Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection

Who this might be right for
Influenza A
Janssen Research & Development, LLC 334
Testing effectiveness (Phase 2)Study completedNCT01014806
What this trial is testing

Evaluate the Safety and Immunogenicity of a Seasonal Influenza Virus-Like Particle (VLP) Vaccine in Older Adults

Who this might be right for
Influenza
Novavax 467
Testing effectiveness (Phase 2)Study completedNCT00115531
What this trial is testing

Eldery High Dose TIV 2005

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 414
Early research (Phase 1)Study completedNCT05561673
What this trial is testing

A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years

Who this might be right for
Hepatitis B
GlaxoSmithKline 122
Large-scale testing (Phase 3)Study completedNCT01162122
What this trial is testing

Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects

Who this might be right for
Influenza
Novartis Vaccines 7,109
Early research (Phase 1)Active Not RecruitingNCT06442241
What this trial is testing

A Safety and Immunogenicity Trial of a Respiratory Syncytial Virus Vaccine, LYB005 in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus (RSV)RSV Infection
Guangzhou Patronus Biotech Co., Ltd. 84
Not applicableStudy completedNCT04756466
What this trial is testing

Effect of the Consumption of a Lactobacillus Strain on the Incidence of Covid-19 in the Elderly

Who this might be right for
SARS CoV-2 InfectionElderly
Biosearch S.A. 201
Testing effectiveness (Phase 2)Looking for participantsNCT06794541
What this trial is testing

Evaluate the Safety and Tolerability of Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI)

Who this might be right for
Complicated Intra-abdominal Infections (cIAI)
Tetraphase Pharmaceuticals, Inc 35
Not applicableStudy completedNCT03931239
What this trial is testing

The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Vabiotech 222
Large-scale testing (Phase 3)Study completedNCT03859141
What this trial is testing

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml)

Who this might be right for
Seasonal Influenza
Sinovac Biotech Co., Ltd 2,340
Large-scale testing (Phase 3)Active Not RecruitingNCT07275645
What this trial is testing

A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10 to 60 Years

Who this might be right for
Rabies
Ab&B Bio-tech Co., Ltd.JS 3,000
Next Page